KRO KRONOS WORLDWIDE INC
Industrial Inorganic Chemicals · NYSE · SEC CIK 1257640 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.7%
TTM net income YoY9.0%
TTM EPS YoY5.7%
Revenue 3-yr CAGR8.0%
Net income 3-yr CAGR—
Margins
Gross margin15.3%
Operating margin2.2%
Net margin-1.9%
FCF margin—
EBITDA margin5.3%
Returns
ROE-4.7%
ROA-2.1%
ROIC (approx.)2.6%
Asset turnover1.11x
Leverage & solvency
Liabilities / assets55.0%
Debt / equity0.69x
Current ratio3.30x
Interest coverage0.80x
Cash quality & payout
Operating cash flow / net income-3.91x
Accruals ratio-10.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $541.10M | $558.10M | $509.80M | $418.30M | $456.90M | $494.40M | $489.80M | $423.10M |
| Cost of revenue | $413.70M | $455.30M | $426.50M | $421.90M | $409.90M | $431.60M | $383.00M | $336.70M |
| Gross profit | $127.40M | $102.80M | $83.30M | -$3.60M | $47.00M | $62.80M | $106.80M | $86.40M |
| SG&A expense | $66.80M | $64.50M | $63.60M | $59.90M | $61.60M | $62.10M | $61.60M | $51.20M |
| Operating income | $57.90M | $37.60M | $12.60M | -$63.10M | -$19.20M | $7.40M | $38.40M | $28.60M |
| Interest expense | $13.40M | $14.20M | $14.30M | $14.50M | $14.10M | $12.80M | $11.60M | $12.10M |
| Pretax income | $44.00M | $22.90M | -$2.00M | -$88.30M | -$29.10M | -$5.70M | $25.70M | $15.50M |
| Income tax | $9.20M | $7.70M | $2.80M | -$5.50M | $7.90M | $3.50M | $7.60M | $28.70M |
| Net income | $34.80M | $15.20M | -$4.80M | -$82.80M | -$37.00M | -$9.20M | $18.10M | -$13.20M |
| EBITDA | $73.20M | $53.40M | $28.00M | -$47.20M | -$3.60M | $22.50M | $52.30M | $42.70M |
| EPS (basic) | 0.30 | 0.13 | -0.04 | — | -0.32 | -0.08 | 0.16 | — |
| EPS (diluted) | 0.30 | 0.13 | -0.04 | — | -0.32 | -0.08 | 0.16 | — |
| Dividends declared per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Weighted avg. shares (diluted) | 115.10M | 115.10M | 115.00M | — | 115.00M | 115.00M | 115.00M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $32.10M | $26.60M | $25.70M | $33.20M | $36.40M | $27.70M | $28.60M | $114.70M |
| Receivables | — | — | — | — | $334.30M | $347.10M | $355.40M | $291.60M |
| Inventory | $481.30M | $498.30M | $549.30M | $628.60M | $659.10M | $683.50M | $699.80M | $656.70M |
| Current assets | $949.10M | $942.60M | $988.50M | $994.50M | $1.07B | $1.09B | $1.13B | $1.11B |
| PP&E, net | $708.20M | $707.60M | $712.60M | $724.30M | $725.70M | $731.20M | $705.40M | $694.10M |
| Goodwill | $2.60M | $2.60M | $2.60M | $2.60M | $2.60M | $2.60M | $2.60M | $2.60M |
| Total assets | $1.74B | $1.74B | $1.80B | $1.82B | $1.91B | $1.94B | $1.95B | $1.91B |
| Current liabilities | $287.80M | $285.80M | $311.00M | $368.80M | $279.20M | $390.20M | $430.30M | $476.60M |
| Short-term debt | — | — | — | — | — | $87.90M | $81.20M | $78.30M |
| Long-term debt | $539.90M | $569.60M | $602.70M | $557.40M | $626.20M | $501.40M | $476.00M | $429.10M |
| Total debt | $539.90M | $569.60M | $602.70M | $557.40M | $626.20M | $589.30M | $557.20M | $507.40M |
| Total liabilities | $958.80M | $993.00M | $1.05B | $1.07B | $1.10B | $1.09B | $1.10B | $1.10B |
| Shareholders' equity | $784.10M | $751.00M | $745.00M | $751.10M | $804.70M | $846.80M | $847.00M | $817.00M |
| Net debt | $507.80M | $543.00M | $577.00M | $524.20M | $589.80M | $561.60M | $528.60M | $392.70M |
| Shares outstanding | — | — | — | 115.00M | — | — | — | 115.00M |
| Cash flow statement | ||||||||
| Operating cash flow | $52.90M | $53.30M | -$51.30M | $92.10M | -$7.90M | $20.70M | -$102.40M | $49.30M |
| Capital expenditure | — | — | — | $10.20M | $9.50M | $11.20M | $12.00M | $12.30M |
| Free cash flow | — | — | — | $81.90M | -$17.40M | $9.50M | -$114.40M | $37.00M |
| Investing cash flow | -$13.50M | -$16.10M | -$10.20M | -$10.20M | -$9.50M | -$11.20M | -$12.00M | -$12.30M |
| Financing cash flow | -$34.20M | -$36.20M | $53.10M | -$76.20M | $26.00M | -$13.20M | $27.10M | -$20.70M |
| Depreciation & amortization | $15.30M | $15.80M | $15.40M | $15.90M | $15.60M | $15.10M | $13.90M | $14.10M |
| Dividends paid | $5.80M | $5.70M | $5.80M | $5.70M | $5.80M | $5.70M | $5.80M | $5.70M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.